PRESS RELEASES

Recor Medical Endorses European Society of Cardiology’s New Guidelines for Management of Hypertension
September 3, 2024
The new ESC Guidelines for Management of Elevated Blood Pressure and Hypertension were presented at the ESC Congress in London and reinforce the safety and effectiveness of renal denervation, recommending its consideration as a treatment option to improve uncontrolled hypertension.
Read More »
Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise™ Ultrasound Renal Denervation Therapy
November 10, 2023
Innovative new treatment option for patients with uncontrolled hypertension now available in the United States
Read More »
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
November 7, 2023
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.
Read More »
Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023
October 26, 2023
Analysis shows a maintained blood pressure lowering effect with fewer added medications following treatment with the Paradise™ Ultrasound Renal Denervation system
Read More »